<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7C7CB409-715A-4551-90E6-D864BA6D29C5"><gtr:id>7C7CB409-715A-4551-90E6-D864BA6D29C5</gtr:id><gtr:firstName>Bart</gtr:firstName><gtr:surname>De Strooper</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_17116"><gtr:id>11F1C1F9-8CB5-4BC9-9A48-7F7370B5672C</gtr:id><gtr:title>Capital award for UK DRI at University College London</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_17116</gtr:grantReference><gtr:abstractText>Alongside significant co-investment from University College London, the expected outcome of this funding is the concluded refurbishment of three wings in UCL?s Cruciform building to establish an Interim Hub of the UK DRI with capacity for 100 researchers and full occupancy expected by March 2018.. 
Additionally, &amp;pound;2.5m for procurement of capital equipment is being provided to assist the UK DRI in implementing its first scientific programmes (funding provided separately).
Together, the building and equipment will provide the location for, in the initial stages of 8 programmes initially, to grow significantly in number in subsequent years. The UK DRI as a whole will help to cement the UK?s world-leading position by also promoting innovate approaches and forging much closer collaboration and integration of on-going UK research efforts. The new institute has been established to lead the UK?s dementia research effort and forms a core part of achieving the Prime Minister?s Challenge on Dementia 2020.</gtr:abstractText><gtr:technicalSummary>The aim of this award is to support University College London with capital investment for setting-up of the interim hub of the UK Dementia Research Institute (UK DRI) centres; in particular, the capital required for building, refurbishment and the procurement of equipment.

At present, 8 programmes have been selected, planned for the UK DRI at University College London and with scientific and operational leadership provided by its director, Professor Bart De Strooper. The project at University College London will involve refurbishment of three wings in UCL?s Cruciform building to establish an Interim Hub of the UK DRI with capacity for 100 researchers and full occupancy expected by March 2018. This is separate to the final hub location of the UK DRI at UCL, at Queen Square House, but will act as the hub location until 2022 (when those works would be complete).

The approach of the institute as a whole, of which the UK DRI at University College London forms a core part as the central hub, is to amplify and enhance, not replace, current dementia research efforts in the UK. The UK DRI will help to cement the UK?s world-leading position by supplying vital new funding for research, coupled to promoting innovate approaches and forging much closer collaboration and integration of on-going UK research efforts. 

There is a gap in our knowledge of how the healthy brain functions and what leads to its degeneration. The UK DRI will fill this crucial gap that exists at the start of the dementia research journey. It will study the healthy brain and neurodegeneration in order to build new knowledge and understanding that will lead to new treatments. It will also proactively connect to existing clinical and population-level dementia initiatives ? for example as being undertaken by the MRC Dementias Platform UK and through the NIHR TRC-D ? to catalyse a unique national and strategic approach to confronting the dementia challenge.

In particular, the present research at the UK DRI at University College London plans to look at the linking molecular pathway dysfunction with genetic and lifecourse factors; Axonal transport; Single cell analyses of gene expression &amp;amp; biological pathways in AD; New biomarkers to monitor disease progression.. Funding to these science programmes is provided separately.</gtr:technicalSummary><gtr:fund><gtr:end>2020-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2017-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>8000000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>08479153-6A74-410D-B47A-B00C751AA6A2</gtr:id><gtr:title>Correction: Tetraspanin 6: A novel regulator of hippocampal synaptic transmission and long term plasticity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5d8ccd36b3703baf9771cc68f61b3f6"><gtr:id>f5d8ccd36b3703baf9771cc68f61b3f6</gtr:id><gtr:otherNames>Salas IH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a981d7a9c0a32.46336670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6C8FB70-0A5F-4F5A-8296-BD2C7EE4DA5B</gtr:id><gtr:title>microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18092da6c44388cdfcaed2aa5fc61c80"><gtr:id>18092da6c44388cdfcaed2aa5fc61c80</gtr:id><gtr:otherNames>Salta E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5a981d7d379188.45614793</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35CF332F-69C8-450A-A686-63FDF664F6DC</gtr:id><gtr:title>APP mouse models for Alzheimer's disease preclinical studies.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/576eca68a8d0f3618e4309e219dc3e2c"><gtr:id>576eca68a8d0f3618e4309e219dc3e2c</gtr:id><gtr:otherNames>Sasaguri H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5a981d7a4d7be3.01092066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D08C496-3BA1-48F2-B79C-C9BE668E9D65</gtr:id><gtr:title>Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fa3d78d30df8fd4b699a74923ba1f65"><gtr:id>9fa3d78d30df8fd4b699a74923ba1f65</gtr:id><gtr:otherNames>McInnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>5a981d791d73c5.42138994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>584D3454-7CF9-4870-9375-9006BB150663</gtr:id><gtr:title>Inactivation of ?-secretases leads to accumulation of substrates and non-Alzheimer neurodegeneration.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24b103edce05bedf652e8e549710e683"><gtr:id>24b103edce05bedf652e8e549710e683</gtr:id><gtr:otherNames>Acx H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>5a981d7af06240.34759268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC5867B5-6F85-45B7-9B1B-06276B1D08CF</gtr:id><gtr:title>Tetraspanin 6: a pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c034d1d7e28ecec496e17d6c87455879"><gtr:id>c034d1d7e28ecec496e17d6c87455879</gtr:id><gtr:otherNames>Guix FX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>5a981d7c4eb723.21040591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61079396-C766-469C-AF2C-13E896B6E696</gtr:id><gtr:title>Correction: Tetraspanin 6: A novel regulator of hippocampal synaptic transmission and long term plasticity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5d8ccd36b3703baf9771cc68f61b3f6"><gtr:id>f5d8ccd36b3703baf9771cc68f61b3f6</gtr:id><gtr:otherNames>Salas IH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a981d799a16e4.77416979</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59A711FB-B61C-48BC-B3E3-ADD92058558C</gtr:id><gtr:title>Tau association with synaptic vesicles causes presynaptic dysfunction.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/240a27c7bd5d10365eaae398f59768ee"><gtr:id>240a27c7bd5d10365eaae398f59768ee</gtr:id><gtr:otherNames>Zhou L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a981d7b505573.11140160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A16D5B14-C9ED-42C0-9DC8-AE8BFE74C152</gtr:id><gtr:title>Intramembranous processing by ?-secretase regulates reverse signaling of ephrin-B2 in migration of microglia.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3592a6ccbe64ab73998089d4ec118000"><gtr:id>3592a6ccbe64ab73998089d4ec118000</gtr:id><gtr:otherNames>Kemmerling N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>5a981d7beac223.91342347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11F50797-AC6F-44A6-A3A6-0333EE9237E7</gtr:id><gtr:title>Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0c7263a6afc0fd97e5b9b054b81abe3"><gtr:id>a0c7263a6afc0fd97e5b9b054b81abe3</gtr:id><gtr:otherNames>Brownjohn PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>5a981d7c1dce83.36942679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9912EBC5-89F7-4959-AD30-4978C1F201E9</gtr:id><gtr:title>Cardiolipin promotes electron transport between ubiquinone and complex I to rescuedeficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e97f66db6aa8363535322a1ea5a63ce"><gtr:id>7e97f66db6aa8363535322a1ea5a63ce</gtr:id><gtr:otherNames>Vos M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>5a981d7d628c40.03473140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47A79FB1-97E2-48DB-8294-C8FBDC1AA827</gtr:id><gtr:title>Modulation of BACE1 Activity by Chemically Modified Aptamers.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c2dc592fc4a667216d856eba03ab942"><gtr:id>8c2dc592fc4a667216d856eba03ab942</gtr:id><gtr:otherNames>Gasse C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>5a981d79441224.30687704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AA0C777-9746-4FD1-9E7F-F39E863278D4</gtr:id><gtr:title>High fat diet treatment impairs hippocampal long-term potentiation without alterations of the core neuropathological features of Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5d8ccd36b3703baf9771cc68f61b3f6"><gtr:id>f5d8ccd36b3703baf9771cc68f61b3f6</gtr:id><gtr:otherNames>Salas IH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>5a981d78e41f96.39556430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38D159D3-B97D-4142-BF28-4FF8AFF26F4C</gtr:id><gtr:title>Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7628656cbaac55543395698763a0f44f"><gtr:id>7628656cbaac55543395698763a0f44f</gtr:id><gtr:otherNames>Hammad H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5a981d7dbfd5e8.21029156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7407D53-8C77-406B-83EC-137211AC475B</gtr:id><gtr:title>Alzheimer's-Causing Mutations Shift A? Length by Destabilizing ?-Secretase-A?n Interactions.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32ecc496cfc58fe47a24f63fed6cae19"><gtr:id>32ecc496cfc58fe47a24f63fed6cae19</gtr:id><gtr:otherNames>Szaruga M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>5a981d7a7798d1.07930914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3E4CD68-22E2-4A3C-9042-1F6B063530E6</gtr:id><gtr:title>Noncoding RNAs in neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18092da6c44388cdfcaed2aa5fc61c80"><gtr:id>18092da6c44388cdfcaed2aa5fc61c80</gtr:id><gtr:otherNames>Salta E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn><gtr:outcomeId>5a981d79ed30c3.40947439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5920A7D9-74D2-4DD5-B38E-357FDB3AB13E</gtr:id><gtr:title>Tetraspanin 6: A novel regulator of hippocampal synaptic transmission and long term plasticity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5d8ccd36b3703baf9771cc68f61b3f6"><gtr:id>f5d8ccd36b3703baf9771cc68f61b3f6</gtr:id><gtr:otherNames>Salas IH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a981d7cb31233.13963160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57226674-29E1-482B-961C-ABD29084F0B1</gtr:id><gtr:title>Identification and characterization of Nanobodies targeting the EphA4 receptor.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88c44e8bbf80781ab251d896802f0a41"><gtr:id>88c44e8bbf80781ab251d896802f0a41</gtr:id><gtr:otherNames>Schoonaert L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5a981d7b289ac9.95077250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAE999E3-FF2A-4EFF-AFB0-94316D67C510</gtr:id><gtr:title>Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APPmice before prominent plaque deposition.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df37282bb772b714c9c5be425b07b4d"><gtr:id>2df37282bb772b714c9c5be425b07b4d</gtr:id><gtr:otherNames>Latif-Hernandez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>5a981d79707e09.92823646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BD697BC-56D7-4BA9-9E26-50A1C9B2CD26</gtr:id><gtr:title>Hallmarks of Alzheimer's Disease in Stem-Cell-Derived Human Neurons Transplanted into Mouse Brain.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5206e4ebbf11b20d8f8f3fd2f592048f"><gtr:id>5206e4ebbf11b20d8f8f3fd2f592048f</gtr:id><gtr:otherNames>Espuny-Camacho I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>5a981d7c8da590.89618757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FD6EDC2-1974-4E36-94EE-29408F273BBD</gtr:id><gtr:title>PLD3 gene and processing of APP.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26fe1baf22f1bd31ba71cd427d7e1883"><gtr:id>26fe1baf22f1bd31ba71cd427d7e1883</gtr:id><gtr:otherNames>Fazzari P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a981d7d95e440.87445603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5B34065-9D24-441F-AAB3-677347D6E8A7</gtr:id><gtr:title>Modulation of ?- and ?-Secretases as Early Prevention Against Alzheimer's Disease.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9016088903c9e979655cde724351fc05"><gtr:id>9016088903c9e979655cde724351fc05</gtr:id><gtr:otherNames>Voytyuk I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>5a981d79c2a9c2.54808010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50179E37-0728-4D97-A6BD-8C843EDE569D</gtr:id><gtr:title>Screening and Characterization Strategies for Nanobodies Targeting Membrane Proteins.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65cea15a7b43c12326cab8a3a440f459"><gtr:id>65cea15a7b43c12326cab8a3a440f459</gtr:id><gtr:otherNames>Veugelen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>5a981d7e04a1e1.02822297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>068F7772-00E7-4FF8-81B6-2FF92B1CB227</gtr:id><gtr:title>Alzheimer's disease: where next for anti-amyloid therapies?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a981d7ba6b573.65153839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4026D728-8CD2-4159-966B-E61B6BBBCC63</gtr:id><gtr:title>BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bdccc1ed7eb32945bbbd3f7e6999f98"><gtr:id>3bdccc1ed7eb32945bbbd3f7e6999f98</gtr:id><gtr:otherNames>Timmers M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>5a981d7cdec407.39668125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93CEDF2F-C01A-4121-89DF-18BE765F16EA</gtr:id><gtr:title>Deletion of exons 9 and 10 of the Presenilin 1 gene in a patient with Early-onset Alzheimer Disease generates longer amyloid seeds.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b9f42d23f8001ccbcc5061ee3c4f484"><gtr:id>8b9f42d23f8001ccbcc5061ee3c4f484</gtr:id><gtr:otherNames>Le Guennec K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>5a981d7b837976.87629930</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_17116</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>